Sodium Citrate 4% W/v Anticoagulant Injection, Solution
Product Images NDC 14537-881

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Sodium Citrate 4% W/v Anticoagulant (NDC 14537-881). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Terumo Bct, Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel (250 mL Bag Carton Label)

Principal Display Panel (250 mL Bag Carton Label)
This is a description of Sodium Citrate 4% wiv Anticoagulant Solution USP, a sterile and non-pyrogenic solution designed for automated apheresis procedures. It is available in 30 x 250 mL units and is manufactured by TerumoBCT, Inc. The solution is recommended to be stored up to 25°C and protected from freezing. Each 100 mL of the solution contains Sodium Citrate Dihydrate 409 and Water for Injection to 100mL with a pH adjusted using citric acid, with approximate millimol of Sodium Citrate 128. The package insert should be read before application and caution needs to be exercised to ensure that the solution is clear, and the container is intact before use. It is a single-use container and should not be used for direct intravenous infusion. Lot expiry date is available, but it was not provided in the description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.